Sumatriptan succinate (GR 43175) is an orally active 5-HT1 receptor agonist with K i s of 17 nM, 27 nM and 100 nM for 5-HT1D, 5-HT1B and 5-HT1A receptors, respectively. Sumatriptan succinate can be used for migraine headache research.
性状
Solid
IC50 & Target[1][2]
5-HT1D Receptor 17 nM (Ki) 5-HT1B Receptor
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
ClinicalTrial
参考文献
[1]. S J Peroutka, et al. Sumatriptan (GR 43175) interacts selectively with 5-HT1B and 5-HT1D binding sites. Eur J Pharmacol. 1989 Apr 12;163(1):133-6. [2]. K L Dechant, et al. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs. 1992 May;43(5):776-98.
溶解度数据
In Vitro: H2O : ≥ 100 mg/mL (241.84 mM)DMSO : 50 mg/mL (120.92 mM; Need ultrasonic)